Voyageur Pharmaceuticals Stock Buy Hold or Sell Recommendation
| VM Stock | CAD 0.06 0.01 8.33% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Voyageur Pharmaceuticals is 'Strong Sell'. Macroaxis provides Voyageur Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding VM positions. The advice algorithm takes into account all of Voyageur Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Voyageur Pharmaceuticals' buy or sell advice are summarized below:
Real Value 0.0525 | Hype Value 0.06 | Market Value 0.055 | Naive Value 0.055 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Voyageur Pharmaceuticals given historical horizon and risk tolerance towards Voyageur Pharmaceuticals. When Macroaxis issues a 'buy' or 'sell' recommendation for Voyageur Pharmaceuticals, the advice is generated through an automated system that utilizes algorithms and statistical models.
Voyageur |
Execute Voyageur Pharmaceuticals Buy or Sell Advice
The Voyageur recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Voyageur Pharmaceuticals. Macroaxis does not own or have any residual interests in Voyageur Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Voyageur Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Voyageur Pharmaceuticals Trading Alerts and Improvement Suggestions
| Voyageur Pharmaceuticals generated a negative expected return over the last 90 days | |
| Voyageur Pharmaceuticals has high historical volatility and very poor performance | |
| Voyageur Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Voyageur Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company currently holds 40 K in liabilities with Debt to Equity (D/E) ratio of 28.1, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Voyageur Pharmaceuticals has a current ratio of 0.16, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Voyageur Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Voyageur Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Voyageur Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Voyageur to invest in growth at high rates of return. When we think about Voyageur Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (1.4 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Voyageur Pharmaceuticals currently holds about 27.59 K in cash with (991.25 K) of positive cash flow from operations. | |
| Latest headline from news.google.com: Closing Bell Voyageur Pharmaceuticals Ltd down on Friday - The Globe and Mail |
Voyageur Pharmaceuticals Returns Distribution Density
The distribution of Voyageur Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Voyageur Pharmaceuticals' future price movements. The chart of the probability distribution of Voyageur Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Voyageur Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Voyageur Pharmaceuticals returns is essential to provide solid investment advice for Voyageur Pharmaceuticals.
| Mean Return | -0.2 | Value At Risk | -8.33 | Potential Upside | 8.33 | Standard Deviation | 7.25 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Voyageur Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Voyageur Pharmaceuticals Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (72.6K) | 810K | (781.4K) | (29.5K) | (26.5K) | (25.2K) | |
| Free Cash Flow | (434.1K) | (2.1M) | (2.0M) | (1.2M) | (1.0M) | (996.9K) | |
| Capital Expenditures | 161.9K | 432.1K | 282.9K | 174.7K | 200.9K | 178.8K | |
| End Period Cash Flow | 3.0K | 813.0K | 31.6K | 2.1K | 1.9K | 1.8K | |
| Net Income | (1.1M) | (2.1M) | (1.8M) | (1.4M) | (1.3M) | (1.2M) | |
| Net Borrowings | 31.8K | 22.4K | 223.7K | (18.9K) | (21.7K) | (20.6K) | |
| Change To Netincome | (15.1K) | 2.7K | 275.5K | 737.6K | 848.2K | 890.7K | |
| Investments | (151.8K) | (432.1K) | (274.2K) | (174.7K) | (157.2K) | (165.1K) | |
| Depreciation | 1.5K | 2.2K | 9.2K | 2.2K | 2.5K | 3.4K |
Voyageur Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Voyageur Pharmaceuticals or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Voyageur Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Voyageur stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.29 | |
β | Beta against NYSE Composite | 1.13 | |
σ | Overall volatility | 7.29 | |
Ir | Information ratio | -0.04 |
Voyageur Pharmaceuticals Volatility Alert
Voyageur Pharmaceuticals is displaying above-average volatility over the selected time horizon. Voyageur Pharmaceuticals is a penny stock. Although Voyageur Pharmaceuticals may be in fact a good investment, many penny stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Voyageur Pharmaceuticals. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Voyageur instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Voyageur Pharmaceuticals Fundamentals Vs Peers
Comparing Voyageur Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Voyageur Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Voyageur Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Voyageur Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Voyageur Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Voyageur Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Voyageur Pharmaceuticals to competition |
| Fundamentals | Voyageur Pharmaceuticals | Peer Average |
| Return On Equity | -0.96 | -0.31 |
| Return On Asset | -0.36 | -0.14 |
| Current Valuation | 7.67 M | 16.62 B |
| Shares Outstanding | 138.81 M | 571.82 M |
| Shares Owned By Insiders | 10.21 % | 10.09 % |
| Number Of Shares Shorted | 9.54 K | 4.71 M |
| Price To Book | 6.28 X | 9.51 X |
| EBITDA | (1.34 M) | 3.9 B |
| Net Income | (1.4 M) | 570.98 M |
| Cash And Equivalents | 27.59 K | 2.7 B |
| Total Debt | 40 K | 5.32 B |
| Debt To Equity | 28.10 % | 48.70 % |
| Current Ratio | 0.16 X | 2.16 X |
| Book Value Per Share | 0.01 X | 1.93 K |
| Cash Flow From Operations | (991.25 K) | 971.22 M |
| Short Ratio | 1.26 X | 4.00 X |
| Earnings Per Share | (0.01) X | 3.12 X |
| Target Price | 0.55 | |
| Beta | 0.49 | -0.15 |
| Market Capitalization | 7.63 M | 19.03 B |
| Total Asset | 2.16 M | 29.47 B |
| Retained Earnings | (9.13 M) | 9.33 B |
| Working Capital | (585.25 K) | 1.48 B |
| Net Asset | 2.16 M |
Voyageur Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Voyageur . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Voyageur Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Voyageur Pharmaceuticals? Buying financial instruments such as Voyageur Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Total Current Liabilities | 591.3K | 673.9K | 775.0K | 418.5K | Total Assets | 2.1M | 2.2M | 2.5M | 2.6M |
Use Investing Ideas to Build Portfolios
In addition to having Voyageur Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Tech Funds Thematic Idea Now
Tech Funds
Funds or Etfs that invest in companies involved in research, development, testing, or distribution of technologically based goods and services. The Tech Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Tech Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Voyageur Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Voyageur Stock analysis
When running Voyageur Pharmaceuticals' price analysis, check to measure Voyageur Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Voyageur Pharmaceuticals is operating at the current time. Most of Voyageur Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Voyageur Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Voyageur Pharmaceuticals' price. Additionally, you may evaluate how the addition of Voyageur Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance |